All Journals All Articles | Search Log In
Articles Special Topics Volumes Webinars Videos
Articles Special Topics Volumes Webinars Interviews

Volume

Circular RNA hsa-circ-0001030 suppresses proliferation and cisplatin tolerance in TSCC via interaction with PKM2

Identification of antibody-drug conjugate payloads that are substrates of ATP-binding cassette drug efflux transporters

Novel anti-tumor strategies: targeting the crosstalk between cancer stem cells and cancer-associated fibroblasts to resist drug resistance

Extracellular vesicles shed by multidrug resistant cells contribute to the identification of SRC inhibitors as chemosensitizers in non-small cell lung cancer

Evaluation of intracellular nucleotide pools in peripheral blood and bone marrow mononuclear cells and their association with frontline intensive chemotherapy response rates in AML patients

TROP2-targeting antibody–drug conjugates in breast cancer and ovarian carcinoma: therapeutic advances and resistance mechanisms

From EGFR PTM network to TKI resistance: spatial subtypes and targeting in lung cancer

Conjugated oligoelectrolytes overcome cancer drug resistance by dual-mode lysosomal membrane disruption

Multi-omics classification of acute myeloid leukemia guides drug combinations to overcome Venetoclax resistance

Immunotherapy resistance and strategies in malignant pleural mesothelioma

Roles and potential applications of non-coding RNAs in cancer treatment with immune checkpoint inhibitors and immunomodulatory therapies

Nanomaterial-based strategies overcome PD-1 related intrinsic immune resistance

Paired single cell analysis reveals chemotherapy resistance in osteosarcoma

Ultrasonic modulation of brain glymphatic transport: from observations to theranostic applications

Novel <i>N</i>-chloroacetyl-2-pyrazoline analogs with 2-naphthyl and ferrocenyl groups: targeting histamine receptor H1 to overcome colorectal cancer drug resistance

Tumor heterogeneity as a driver of drug resistance and its implications for personalized therapy

Overcoming resistance to anti-PD-1/PD-L1 therapy in cancer

TRAP1 ablation improves mitochondrial cristae and oxidative phosphorylation in pancreatic cancer stem cells

Deep spatial proteomics reveals a suppressive immune niche linked to immune evasion in renal cell carcinoma

A systematic review and network meta analysis of first-line immunotherapy for advanced urothelial carcinoma

Fenretinide in cancer therapy and chemoprevention: past, present and future

Unveiling the role of UGT enzymes in chemoresistance: a path to enhanced cancer pharmacotherapy

LINC01607 promotes hepatocellular carcinoma progression and ferroptosis-associated therapy resistance with functional involvement of the p62–Keap1–Nrf2 pathway

Lack of resolution of inflammation marks malignant pleural mesothelioma progression

An epithelial-mesenchymal transition-related gene signature predicts prognosis, immune infiltration, and drug sensitivity in colorectal cancer

Mechanistic roles and clinical applications of tertiary lymphoid structures in colorectal cancer drug resistance

TET2 downregulation limits oxidative stress-induced cytotoxicity of high dose ascorbate in dabrafenib-resistant melanoma cells

Mitochondrial LINC01133 regulates pyroptosis and calcium homeostasis in cisplatin-resistant lung adenocarcinoma

Adenylosuccinate lyase in pancreatic ductal adenocarcinoma chemoresistance: from purine metabolism to metabolic vulnerability

Divergent transcriptional programs and constrained metabolic states reveal selective metabolic dependencies in chemoresistant luminal breast cancer

Bracing for the storm: emerging resistance mechanisms to KRAS inhibitors in pancreatic cancer and strategies to overcome them

ST6GAL1 promotes cancer stem-like cell-associated paclitaxel resistance through the EGFR-mTOR-SOX2/BMI1 axis in non-small cell lung cancer

Resistance to third-generation EGFR TKIs - what can be expected from the fourth-generation?

PSMD14 as a translational target in cancer and beyond: from deubiquitination mechanisms to drug resistance and precision therapy

Adaptive drug resistance in melanoma is characterised by lipidome remodelling while maintaining cell membrane biophysical properties

Actions for 0 selected articles

Cancer Drug Resistance
ISSN 2578-532X (Online)
Navigation
Follow Us
Navigation

Committee on Publication Ethics

https://members.publicationethics.org/members/cancer-drug-resistance

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Committee on Publication Ethics

https://members.publicationethics.org/members/cancer-drug-resistance

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/
Contact Us
Follow OAE
Twitter
Facebook
LinkedIn
YouTube
BiLiBiLi
WeChat
Rss
© 2016-2026 OAE Publishing Inc., except certain content provided by third parties